CompletedPhase 2NCT00049179
S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- SWOG Cancer Research Network
- Principal Investigator
- John E. Godwin, MD, MSLoyola University
- Intervention
- cytarabine(drug)
- Enrollment
- 33 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2003 – 2010
Study locations (30)
- Alta Bates Comprehensive Cancer Center, Berkeley, California, United States
- Mills-Peninsula Health Services, Burlingame, California, United States
- Marin Cancer Institute at Marin General Hospital, Greenbrae, California, United States
- Sutter Health Western Division Cancer Research Group, Greenbrae, California, United States
- Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange, California, United States
- California Pacific Medical Center - California Campus, San Francisco, California, United States
- Phoebe Cancer Center at Phoebe Putney Memorial Hospital, Albany, Georgia, United States
- Piedmont Hospital, Atlanta, Georgia, United States
- CCOP - Atlanta Regional, Atlanta, Georgia, United States
- Northside Hospital Cancer Center, Atlanta, Georgia, United States
- Saint Joseph's Hospital of Atlanta, Atlanta, Georgia, United States
- WellStar Cobb Hospital, Austell, Georgia, United States
- Charles B. Eberhart Cancer Center at DeKalb Medical Center, Decatur, Georgia, United States
- Gwinnett Medical Center, Lawrenceville, Georgia, United States
- Kennestone Cancer Center at Wellstar Kennestone Hospital, Marietta, Georgia, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00049179 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.